[ERB] ERBA Diagnostics, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 0.51 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart ERB

Refresh chart

Description: ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products in Italy; and develops, manufactures, and markets diagnostic equipment, as well as raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -35.65% Sales Growth - Q/Q-19.25% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-3% ROE-4.33% ROI
Current Ratio2.82 Quick Ratio1.49 Long Term Debt/Equity Debt Ratio0.35
Gross Margin47.31% Operating Margin-0.2% Net Profit Margin-2.95% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities-290 K Cash From Operating Activities-150 K Gross Profit2.1 M
Net Profit-1.02 M Operating Profit-670 K Total Assets24.49 M Total Current Assets16.85 M
Total Current Liabilities5.98 M Total Debt1.94 M Total Liabilities7.53 M Total Revenue4.85 M
Technical Data
High 52 week1.24 Low 52 week0.48 Last close0.5 Last change0%
RSI Average true range Beta0.57 Volume
Simple moving average 20 days0% Simple moving average 50 days0% Simple moving average 200 days-14.11%
Performance Data
Performance Week0% Performance Month0% Performance Quart0% Performance Half-7.41%
Performance Year-57.63% Performance Year-to-date0% Volatility daily0% Volatility weekly0%
Volatility monthly0% Volatility yearly0% Relative Volume0% Average Volume
New High New Low

News

2019-05-27 07:44:18 | You Might Like Erbud S.A. WSE:ERB But Do You Like Its Debt?

2018-06-24 04:01:03 | Does Erbud SA’s WSE:ERB PE Ratio Warrant A Buy?

2018-05-05 03:27:33 | Where Erbud SA.’s WSE:ERB Earnings Growth Stands Against Its Industry

2016-09-30 17:41:08 | ERBA Diagnostics to Commence Trading on OTC Markets' Pink Open Market After Delisting by the NYSE MKT

2016-09-30 16:06:57 | ERBA DIAGNOSTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan

2016-09-29 16:30:03 | ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards

2016-09-29 16:11:31 | ERBA DIAGNOSTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits

2016-09-29 16:05:00 | ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards

2016-09-07 16:16:43 | ERBA DIAGNOSTICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Ex

2016-08-26 16:38:05 | ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards

2016-08-26 16:15:00 | ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards

2016-05-31 17:03:10 | ERBA Diagnostics, Inc. Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors

2016-05-20 16:33:02 | ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan

2016-04-21 16:52:16 | ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards

2016-02-26 13:06:00 | SHAREHOLDER ALERT: ERBA Diagnostics, Inc. _ERB_ is the Subject of a Legal Investigation

2016-02-01 12:13:00 | DEADLINE TODAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016

2016-02-01 10:00:00 | DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016

2016-01-31 15:59:00 | DEADLINE NOTICE: Scott + Scott, LLP Reminds Investors of Monday, February 1, 2016 Lead Plaintiff Deadline in the ERBA Diagnostics, Inc. Securities Lawsuit

2016-01-29 14:42:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - ERB

2016-01-29 13:48:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016

2016-01-29 09:43:00 | FINAL SHAREHOLDER NOTICE: Scott + Scott, LLP Reminds Investors that Monday, February 1, 2016 Is the Final Day to File Lead Plaintiff Papers in the Securities Lawsuit Against ERBA Diagnostics, Inc. - ERB

2016-01-27 08:14:10 | ERBA Diagnostics' Compliance Plan Accepted by NYSE MKT

2016-01-25 16:19:00 | INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016 -- ERB

2016-01-22 11:00:00 | SHAREHOLDERS ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016

2016-01-20 10:00:00 | Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016

2016-01-18 14:28:00 | Lifshitz & Miller Law Firm Announces Investigation of BofI Holding, Inc., Capstone Turbine Corporation, Dr. Reddy's Laboratories Ltd., ERBA Diagnostics, Inc., Identiv, Inc., Osiris Therapeutics, Inc., and XBiotech Inc.

2016-01-18 10:51:00 | ERB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016

2016-01-12 11:24:00 | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 - ERB

2016-01-04 17:38:00 | DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in ERBA Diagnostics, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

2016-01-04 12:28:22 | INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ERBA Diagnostics, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 1, 2016 -- ERB

2016-01-01 08:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in ERBA Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline -- ERB

2015-12-30 21:16:00 | DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against ERBA Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2015-12-29 08:24:05 | ERBA Diagnostics, Inc. Announces the Consummation of the Capital Infusion of $3.5 Million Into the Company

2015-12-28 19:34:00 | IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against ERBA Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

2015-12-28 14:23:00 | Robbins Arroyo LLP: ERBA Diagnostics, Inc. ERB Misled Shareholders According to a Recently Filed Class Action

2015-12-21 13:02:00 | ERBA Diagnostics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors